In this situation, the presence of the leukemia-specific BCR-ABL gene can be monitored using the molecular approach, particularly quantitative RT PCR to quantify the level of BCR-ABL mRNA in peripheral blood (Jabbour et al., 2008). This evidence concerns the gene ABL1 and leukemia.